Tafenoquine and ACTs (TADORE- Plus)

NCT07060794 · clinicaltrials.gov ↗

PHASE4

Phase

NOT_YET_RECRUITING

Status

507

Enrollment

OTHER

Sponsor class

Conditions

Vivax Malaria

Interventions

DRUG: Tafenoquine plus DHA-Piperaquine
DRUG: Tafenoquine plus Artesunate-pyronaridine

Sponsor

Menzies School of Health Research